Targeted antibodies in dairy-based products

Advances in Experimental Medicine and Biology

Volumn 606, Issue , 2008, Pages 321-343

  Hammarström, Lennart ^a   Weiner, Carina Krüger ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BOVINE ANTIBODY; IMMUNOGLOBULIN G; OMEPRAZOLE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC PROPHYLAXIS; CANDIDIASIS; CHOLERA; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; COLOSTRUM; CONTROLLED CLINICAL TRIAL; CRYPTOSPORIDIOSIS; DAIRY PRODUCT; DENTAL CARIES; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; HELICOBACTER INFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; ROTAVIRUS; SHIGELLA FLEXNERI; SHIGELLOSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MUTANS; THRUSH; TREATMENT DURATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 84934436563     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74087-4_13     Document Type: Review

References (107)

1. Aaltonen, A. S., Tenovuo, J., Lehtonen, O. P.,& Saksala, R. (1990). Maternal caries incidence and salivary close-contacts with children affect antibody levels to Streptococcus mutans in children. Oral Microbiology and Immunology, 5, 12-18.
2. Abrams, G. D., Allo, M., Rifkin, G. D., Fekety, R., & Silva, J., Jr. (1980). Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut, 21, 493-499.
3. Abcres, S. D., Isaacson, R. E., Babiuk, L. A.,&Kapitany, R. A. (1979). Immunization of calves against enterotoxigenic Colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins. Infectious Immunology, 25, 121-126.
4. Ando, K., & Nakamura, T. (1991). A method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis and thus formulated medicines. European patent application no. 91310049.1.
5. Bogstedt, A. K., Hammarström, L., & Robertson, A. K. (1997). Survival of immunoglobulins from different species through the gastrointestinal tract in healthy adult volunteers: Implications for human therapy. Antimicrobial Agents of Chemotherapy, 41, 2320.
6. Brinkworth, G. D., & Buckley, J. D. (2003). Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males. European Journal of Nutrition, 42, 228-232.
7. Brock, J. H., Ortega, F., & Pineiro, A. (1975). Bactericidal and haemolytic activity of complement in bovine colostrum and serum: Effect of proteolytic enzymes and ethylene glycol tetraacetic acid (EGTA). Annals of Immunology, 126C, 439-451.
8. Brown, W. R., Rabbani, H., Butler, J. E., & Hammarström, L. (1997). Characterization of the bovine Ca gene. Immunology, 91, 1-6.
9. Brunser,O., Espinoza, J., Figueroa, G.,Araya, M., Spencer, E., Hilpert, H., Link-Amster, H.,& Brüssow, H. (1992). Field trial of an infant formula containing anti-rotavirus and anti-Escherichia coli milk antibodies from hyperimmunized cows. Journal of Pediatric Gastroenterology and Nutrition, 15, 63-72.
10. Butler, J. E. (1983). Bovine immunoglobulins: An augmented review. Veterinary Immunology and Immunopathology, 4, 43-152.
11. Butler, J. E., Kiddy, C. A., Pierce, C. S., & Rock, C. A. (1972a). Quantitative changes associated with calving in the levels of bovine immunoglobulins in selected body fluids. I. Changes in the levels of IgA, IgG1 and total protein. Canadian Journal of Comparative Medicine, 36, 234-242.
12. Butler, J. E., Maxwell, C. F., Pierce, C. S., Hylton, M. B., Asofsky, R., & Kiddy, C. A. (1972b). Studies on the relative synthesis and distribution of IgA and IgG1 in various tissues and body fluids of the cow. Journal of Immunology, 109, 38-46.
13. Butler, J. E., Seawright, G. L., McGivern, P. L., & Gilsdorf, M. (1986). Preliminary evidence for a diagnostic immunoglobulin G1 antibody response among culture-positive cows vaccinated with Brucella abortus strain 19 and challenge exposed with strain 2308. American Journal of Veterinary Research, 47, 1258-1264.
14. Casswall, T. H., Sarker, S. A., Albert, M. J., Fuchs, G. J., Bergström, M., Björk, L., & Hammarström, L. (1998). Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Alimentary Pharmacology and Therapy, 12, 563-568.
15. Casswall, T. H., Sarker, S. A., Faruque, S. M., Weintraub, A., Albert, M. J., Fuchs, N., Dahlström, A. K., Link, H., Brüssow, H., & Hammarström, L. (2000). Treatment of enterotoxigenic and enteropathogenic Escherichia coli induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: A double-blind, placebo-controlled, clinical trial. Scandinavian Journal of Gastroenterology, 7, 711-718.
16. Casswall, T. H., Nilsson, H. O., Björck, L., Sjöstedt, S., Xu, L., Nord, C. K., Boren, T., Wadström, T., & Hammarström, L. (2002). Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scandinavian Journal of Gastroenterology, 37, 1380-1385.
17. Cloud, J., & Kelly, C. P. (2007). Update on Clostridium difficile associated disease. Current Opinion in Gastroenterology, 23, 4-9.
18. Crooks, C. V., Wall, C. R., Cross, M. L., & Rutherford-Markwick, K. J. (2006). The effects of bovine colostrum supplementation on salivary IgA in distance runners. International Journal of Sport Nutrition and Exercise Metabolism, 16, 47-64.
19. Davidson, G. P., Daniels, E., Nunan, H., Moore, A. G., Whyte, P. B. D., Franklin, K., McCloud, P. I., & Moore, D. J. (1989). Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet, 2, 709-712.
20. Davidson, G. P., Tam, J., & Kirubacaran, C. (1994). Passive protection against symptomatic hospital acquired rotavirus infection in India and Hong Kong. Journal of Pediatric Gastroenterology and Nutrition, 19, 351.
21. Ebina, T., Sato, A., Umezu, K., Ishida, N., Ohyama, S., Oizumi, A., Aikawa, K., Katagiri, S., Katsushima, N., Imai, A., Kitaoka, S., Suzuki, H., & Konno, T. (1985). Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody. Medical Microbiology and Immunology, 174, 177-185.
22. Fayer, R., & Jenkins, M. C. (1992). Colostrum from cows immunized with Eimeria acervulina antigens reduces parasite development in vivo and in vitro. Poultry Science, 71, 1637-1645.
23. Fayer, R., Andrews, C., Ungar, B. L.,&Blagburn, B. (1989). Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. Journal of Parasitology, 75, 393-397.
24. Fayer, R., Guidry, A., & Blagburn, B. L. (1990). Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice. Infectious Immunology, 58, 2962-2965.
25. Filler, S. J., Gregory, R. L., Michalek, S. M., Katz, J., & McGhee, J. R. (1991). Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Archives in Oral Biology, 36, 41-47. Freedman, D. J., Tacket, C. O., Delehanty, A., Maneval, D. R., Nataro, J., & Crabb, J. H. (1998). Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. Journal of Infectious Diseases, 177, 662-667.
26. Funatogawa, K., Ide, T., Kirikae, F., Saruta, K., Nakano, M., & Kirikae, T. (2002). Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice. Medical Microbiology and Immunology, 46, 761-766.
27. Graczyc, T. K., Cranfield M. R., Helmer, P., Fayer, R., & Bostwick, E. F. (1998). Therapeutic efficacy of hyperimmune bovine colostrum treatment against clinical and subclinical Cryptosporidium serpentis infections in captive snakes. Veterinary Parasitology, 31, 123-132.
28. Greenberg, P. D., & Cello, J. P. (1996). Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. Journal of AIDS, 13, 348-354.
29. Harp, J. A., Woodmansee, D. B., & Moon, H. W. (1989). Effects of colostral antibody on susceptibility of calves to Cryptosporidium parvum infection. American Journal of Veterinary Research, 50, 2117-2119.
30. Hilpert, H., Brüssow, H., Mietens, C., Sidoti, J., Lerner, L., & Werchau, H. (1987). Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. Journal of Infectious Diseases, 156, 158-166.
31. Hoskins, D., Chrisp, C. E., Suckow, M. A.,&Fayer, R. (1991). Effect of hyperimmune bovine colostrum raised against Cryptosporidium parvum on infection of guinea pigs by Cryptosporidium wrairi. Journal of Protozoology, 38, 185S-186S.
32. Howden, C. W. (1996). Clinical expressions of Helicobacter pylori infection. American Journal of Medicine, 100, 27S-32S.
33. Huppertz, H. I., Rutkowski, S., Busch, D. H., Eisebit, R., Lissner, R., & Karch, H. (1999). Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, Shiga toxin-producing E. coli, and E. coli expressing intimin and hemolysin. Journal of Pediatric Gastroenterology and Nutrition, 29, 452-456.
34. Isaacson, R. E., Dean, E. A., Morgan, R. L., & Moon, H. W. (1980). Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified K99 or 987P pili: Antibody production in response to vaccination. Infectious Immunology, 19, 824-826.
35. Jansson, A., Nava, S., Brüssow, H., Mahanalabis, D., & Hammarström, L. (1994). Titers of specific antibodies in immunized and non-immunized colostrum; implications for their use in the treatment of patients with gastrointestinal infections. In Indigenous Antimicrobial Agents of Milk-Recent Developments (pp. 221-228). Brussels: International Diary Federation Press.
36. Jenkins, M. (2004). Present and future control of cryptosporidiosis in humans and animals.Expert Review of Vaccines, 3, 669-671.
37. Jenkins, M. C., O'Brien, C., Trout, J., Guidry, A., & Fayer, R. (1999). Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed mice. Vaccine, 17, 2453-2460.
38. Kacskovics, I., & Butler, J. E. (1996). The heterogeneity of bovine IgG2. VIII. The complete cDNA sequence of bovine IgG2a (A2) and an IgG1. Molecular Immunology, 33, 189-195.
39. Kacskovics, I., Wu, Z., Simister, N. E., & Hammarström, L. (2000). Cloning and characterization of the bovine MHC class I-like Fc receptor. Journal of Immunology, 164, 1889-1897.
40. Kacskovics, I., Kis, Z., Mayer, B., West, A. P., Jr., Tiangco, N. E., Tilahun, M., Cervenak, L., Bjorkman, P. J., Goldsby, R. A., Szenci, O., & Hammarström, L (2006). FcRn mediates elongated serum half-life of human IgG in cattle. International Immunology, 18, 525-536.
41. Kelly, C. P., Chetham, S., Keates, S., Bostwick, E. F., Roush, A. M., Castagliuolo, I., LaMont, J. T., & Pothoulakis, C. (1997). Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrobial Agents of Chemotherapy, 41, 236-241.
42. Kelly, P., & Farthing, M. J. (1998). Bacterial infections of the gut (excluding enteric fever). Current Opinion in Infectious Diseases, 11, 577-582.
43. Koga, T., Oho, T., Shimazaki, Y., & Nakano, Y. (2002). Immunization against dental caries. Vaccine, 20, 2027-2044.
44. Korhonen, H., Syväoja, E.-L., Ahola-Luttila, H., Sivelä, S., Kopola, S, Husu, J., & Kosunen, T. U. (1994). Helicobacter pylori-specific antibodies and bactericidal activity in serum, colostrum and milk of immunised and non immunised cows. Indigenous Antimicrobial Agents of Milk-Recent Developments. IDF Special Issue 9404, 4, 151-163.
45. Korhonen, H., Syvaoja, E. L., Ahola-Luttila, H., Sivela, S., Kopola, S., & Husu, J. (1995). Bactericidal effect of bovine normal and immune serum, colostrums and milk against Helicobacter pylori. Journal of Applied Bacteriology, 78, 655-662.
46. Korhonen, H., Marnila, P., & Gill, H. S. (2000). Bovine antibodies for health. British Journal of Nutrition, 84, S135-S146.
47. Kuroiwa,Y., Kasinathan, P.,Choi,Y. J., Naeem,R., Tomizuka, K., Sullivan, E. J.,Knott, J.G., Duteau, A., Goldsby, R. A., Osborne, B. A., Ishida, I., & Robl, J. M. (2002). Cloned transchromosomic calves producing human immunoglobulin. Nature Biotechnology, 20, 889-894.
48. Leresche, E., Paunier, L., & Andrejevic, G. (1972). Stabilitédans le tractus digestif du nourrisson et tolerance clinique d'immunoglobulines bovines àteneur anticorps elevée contre les E. Coli pathogenes, administrées par voie orale. Comp Immun Microbiol Infect Dis, 1, 205-220.
49. Lissner, R., Schmidt, H., & Karch, H. (1996). A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7. Infection, 24, 378-383.
50. Lissner, R., Thürmann, P. A., Merz, G., & Karch, H. (1997). Antibody reactivity and fecal recovery of bovine immunoglobulins following oral administration of a colostrum concentrate from cows (Lactobin) to healthy volunteers. International Journal of Clinical Pharmacological Therapy, 36, 239-245.
51. Lodinová-Zàdnikovà, R., Korych, B., & Bartakova, Z. (1987). Treatment of gastrointestinal infections in infants by oral administration of colostral antibodies. Die Nahrung, 31, 465-467.
52. Loimaranta, V., Tenovuo, J., Virtanen, S., Marnila, P., Syvaoja, E. L., Tupasela, T., & Korhonen, H. (1997). Generation of bovine immune colostrum against Streptococcus mutans and Streptococcus sobrinus and its effect on glucose uptake and extracallular polysaccharide formation by mutans streptococci. Vaccine, 15, 1261-1268.
53. Loimaranta, V., Carlen, A., Olsson, J., Tenovuo, J., Syvaoja, E. L., & Korhonen, H. (1998). Concentrated bovine colostral whey proteins from Streptococcus mutans/Strep. sobrinus immunized cows inhibit the adherence of Strep. mutans and promote the aggregation of mutans streptococci. Journal of Dairy Research, 65, 599-607.
54. Loimaranta, V., Nuutila, J., Marnila, P., Tenovuo, J., Korhonen, H., & Lilius, E. M. (1999). Colostral proteins from cows immunised with Streptococcus mutans/S. sobrinus support the phagocytosis and killing of mutans streptococci by human leukocytes. Journal of Medical Microbiology, 48, 917-926.
55. Lyerly, D. M., Lockwood, D. E., Richardson, S. H., & Wilkins, T. D. (1982). Biological activities of toxins A and B of Clostridium difficile. Infectious Immunology, 35, 1147-1150.
56. Lyerly, D. M., Bostwick, E. F., Binion, S. B., & Wilkins, T. D. (1991). Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infectious Immunology, 59, 2215-2218.
57. Martin-Gomez, S., Alvarez-Sanchez, M. A., & Rojo-Vazquez, F. A. (2005). Oral administration of hyperimmune anti-Cryptosporidium parvum ovine colostral whey confers a high level of protection against cryptosporidiosis in newborn NMRI mice. Journal of Parasitology, 91, 674-678.
58. Mayer, B., Doleschall, M., Bender, B., Bartyik, J., Bosze, Z., Frenyo, L. V., & Kacskovics, I. (2005). Expression of the neonatal Fc receptor (FcRn) in the bovine mammary gland. Journal of Dairy Research, 72, 107-112.
59. McClead, R. E., & Gregory, S. A. (1984). Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis. Infectious Immunology, 44, 474-478.
60. McClead, R. E., Butler, T., & Rabbani, G. H. (1988). Orally administered bovine colostral anti-cholera toxin antibodies: Results of two clinical trials. American Journal of Medicine, 85, 811-816.
61. Mietens, C., Keinhorst, H., Hilpert, H., Gerber, H., Amster, H., & Pahud, J. J. (1979). Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins. European Journal of Pediatrics, 132, 239-252.
62. Mitchell, H. M. (1999). The epidemiology of Helicobacter pylori. Current Topics in Microbiology and Immunology, 24, 11-30.
63. Mitra, A. K., Mahalanabis, D., Ashraf, H., Unicomb, L., Eeckels R., & Tzipori, S. (1995). Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: A double-blind, controlled clinical trial. Acta Paediatrics, 84, 996-1001.
64. Mousavi, M., Rabbani, H., & Hammarström, L. (1997). Characterization of the bovinegene. Immunology, 92, 369-373.
65. Mousavi, M., Rabbani, H., Pilström, L., & Hammarström, L. (1998). Characterization of the gene for the membrane and secretory form of the IgM heavy-chain constant region gene (Cμ) of the cow (Bos taurus). Immunology, 93, 581-588.
66. Nomoto, K., Matsuoka, K., Hayakawa, K., Ohwaki, M., Kan, T., & Yoshikai, Y. (1992). Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model. Medical Microbiology and Immunology, 181, 87-98.
67. Nord, J., Ma, P., DiJohn, D., Tzipori, S., & Tacket, C. O. (1990). Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS, 4, 581-584.
68. Oona,M., Rägo, T.,Maaroos, H.,Mickelsaar,M., Loivukene, K., Salminen, S.,&Korhonen,K. (1997). Helicobacter pylori children with abdominal complaints: Has immune bovine colostrum some influence on gastritis? Alpe AdrMicrobiol Journal, 6, 49-57.
69. Opekun, A. R., El-Zaimaity, H. M., Osato, M. S., Gilger, M. A., Malaty, H. M., Terry, M., Headon, D. R., &Graham, D. Y. (1999). Novel therapies for Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics, 13, 35-41.
70. Osame, S., Ichijo, S., Ohta, C., Watanabe, T., Benkele, W., & Goto, H. (1991). Efficacy of colostral immunoglobulins for therapeutic and preventive treatments of calf diarrhea. Journal of Veterinary Medical Science, 53, 87-91.
71. Perryman, L. E., Riggs, M. W., Mason, P. H., & Fayer, R. (1990). Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum. Infectious Immunology, 58, 257-259.
72. Playford, R. J., Floyd, D. N., Macdonald, C. E., Calnan, D. P., Adenekan, R. O., Johnson, W., Goodlad, R. A., & Marchbank., T. (1999). Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut, 44, 653-658.
73. ayford, R. J., MacDonald, C. E., Calnan, D. P., Floyd, D. N., Podas, T., Johnson, W., Wicks, A. C., Bashir, O., & Marchbank, T. (2001). Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory druginduced increase in intestinal permeability. Clinical Science, 100, 627-633.
74. Plettenberg, A., Stoehr, A., Stellbrink, H. J., Albrecht, H., & Meigel, W. (1993). A preparation from bovine colostrum in the treatment of HIV positive patients with chronic diarrhea. Clinical Investigations, 71, 42-45.
75. Rabbani, H., Brown, W. R., Butler, J. E., & Hammarström, L. (1997). Polymorphism of the IGHG3 gene in cattle. Immunogenetics, 46, 326-331.
76. Riggs, M. W. (1997). Immunology: Host response and development of passive immunotherapy and vaccines In R. Fayer (Ed.), Cryptosporidium and Cryptosporidiosis (pp. 129-162). Boca Raton, FL: CRC Press.
77. Rokka, S., Korhonen, B. H., Nousiainen, J., & Marnila, P. (2001). Colostral whey concentrate supplement increases complement activity in the sera of neonatal calves. Journal of Dairy Research, 68, 357-367.
78. Roos, N., Mahé, S., Benamouzig, R., Sick, H., Rautureau, J., & Tomé, D. (1995). 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. Journal of Nutrition, 125, 1238-1244.
79. Rump, J. A., Arndt, R., Arnold, A., Bendick, C., Dichtelmüller, H., Franke, M., Helm, B. B., Jäger, H., Kampmann, B., Kolb, P., Kreuz, W., Lissner, R., Meigel, W., Ostendorf, P., Peter, H. H., Plettenberg, A., Schedel, I., Stellbrink, H. W., & Stephan, W. (1992). Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clinical Investigations, 70, 588-594.
80. Sarker, S. A., Casswall, T. H., Mahalanabis, D., Alam, N. H., Albert, M. J., Brüssow, H., Fuchs, G. J., & Hammarström, L. (1998). Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatric Infectious Disease Journal, 17, 1149-1154.
81. Saxon, A., & Weinstein, W. (1987). Oral administration of bovine colostrum anti-Cryptosporidia antibody fails to alter the course of human Cryptosporidios. Journal of Parasitology, 73, 413-415.
82. Schaller, J. P., Saif, L. J., Cordle, C. T., Candler, E., Jr., Winship, T. R.,&Smith, K. L. (1992). Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. Journal of Infectious Diseases, 165, 623-630.
83. Shimazaki, Y., Mitoma, M., Oho, T., Nakano, Y., Yamashita, Y., Okano, K., Nakano, Y., Fukuyama, M., Fujihara, N., Nada, Y., & Koga, T. (2001). Passive immunization with milk produced from an immunized cow prevents oral recolonization by Streptococcus mutans. Clinical and Diagnostic Lab Immunology, 8, 1136-1139.
84. Snodgrass, D. R., Nagy, L. K., Sherwood, D., & Campbell, I. (1982). Passive immunity in calf diarrhea: Vaccination with K99 antigen of enterotoxigenic Escherichia coli and rotavirus. Infectious Immunology, 37, 586-591.
85. Stephan, W., Dichtelmüller, H., & Lissner, R. (1990). Antibodies from colostrum in oral immunotherapy. Journal of Clinical and Chemical Biochemistry, 28, 19-23.
86. Tacket, C. O., Losonsky, G., Link, H., Hoang, Y., Guesry, P., Hilpert, H., & Levine, M. M. (1988). Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. New England Journal of Medicine, 318, 1240-1243.
87. Tacket, C. O., Binion, S., Bostwick, E., Losonsky, G., Roy, M. J., & Edelman, R. (1992). Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. American Journal of Tropical Medicine and Hygiene, 47, 276-283.
88. Tarpila, S., Korhonen, H., & Salminen, S. (1995). Immune colostrum in the treatment of Helicobacter pylori gastritis. In Abstract Book of the 24th International Dairy Congress. Melbourne, Australia (pp. 18-22)..
89. Tawfeek, H. I., Najim, N. H., & Al-Mashikhi, S. (2003). Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: A field trial. International Journal of Infectious Diseases, 7, 120-128.
90. Tollemar, J., Gross, N., Dolgiras, N., Jarstrand, C., Ringdén, O., & Hammarström, L. (1999). Passive immunity against Candida in bone-marrow transplanted patients: Reduction of salivary yeast counts by oral administration of bovine anti-Candida antibodies. Bone Marrow Transplant, 23, 283-290.
91. Tsubokura, K., Berndtson, A., Bogstedt, A., Kaijser, B., Kim, M., Ozeki, M., & Hammarstrom, L. (1997). Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni-infected chickens. Clinical Experiments in Immunology, 108, 451-455.
92. Turner, R. B., & Kelsey, D. K. (1993). Passive immunization for prevention of rotavirus illness in healthy infants. Pediatric Infectious Disease Journal, 12, 718-722.
93. Tzipori, S., Robertson, D., & Chapman, C. (1986). Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. British Medical Journal, 293, 1276-1277.
94. Tzipori, S., Robertson, D., Cooper, D., & White, L. (1987). Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet, 2, 344-345.
95. Ungar, B. L., Ward, D. J., Fayer, R., & Quinn, C. A. (1990). Cessation of Cryptosporidiumassociated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology, 98, 486-489.
96. van Dissel, J. T., de Groot, N., Hensgens, C. M., Numan, S., Kuijper, E. J., Veldkamp, P., & van't Wout, J. (2005). Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: Preclinical and preliminary clinical data. Journal of Medical Microbiology, 54, 197-205.
97. van Zaane, D., Ijzerman, J., & De Leeuw, P. W. (1986). Intestinal antibody response after vaccination and infection with rotavirus of calves fed colostrum with or without rotavirus antibody. Veterinary Immunology and Immunopathology, 11, 45-63.
98. Ward, S. J., Douce, G., Dougan, G., & Wren, B. W. (1999). Local and systemic neutralizing antibody responses, induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile. Infectious Immunology, 67, 5124-5132.
99. Warny, M., Fatimi,A., Bostwick, E. F., Lebel, F., LaMont, J. T., Pothoulakis, C.,&Kelly C. P. (1999). Bovine immunoglobulin concentrate-Clostridium difficile retains C. difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut, 44, 212-217.
100. Weiner, C., Pan, Q., Hurtig, M., Borén, T., Bostwick, E., & Hammarström, L. (1999). Passive immunity against human pathogens using bovine antibodies. Clinical Experiments in Immunology, 116, 193-205.
101. Xu, L. B., Chen, L., Gao, W., & Du, K. H. (2005). Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG. Vaccine, 24, 2131-2140.
102. Ylitalo, S., Uhari, M., Rasi, S., Pudas, J., & Leppaluoto, J. (1998). Rotaviral antibodies in the treatment of rotaviral gastroenteritis. Acta Paediatrics, 87, 264-267.
103. Yolken, R., Losonsky, G. A., Vonderfecht, S., Leister, F., & Wee, S.-B. (1988). Antibody to human rotavirus in cow's milk. New England Journal of Medicine, 312, 605-610.
104. Zhao, Y., Kacskovics, I., Pan, Q., Liberles, D. A., Geli, J., Davis, S. K., Rabbani, H., & Hammarström, L. (2002). Artiodactyl IgD: The missing link. Journal of Immunology, 169, 4408-4416.
105. Zhao, Y., Kacskovics, I., Rabbani, H., & Hammarström, L. (2003). Physical mapping of the bovine immunoglobulin heavy chain constant region gene locus. Journal of Biological Chemistry, 278, 35024-35032.
106. Zhao, Y., Jackson, S. M.,&Aitken, R. (2006). The bovine antibody repertoire. Developmental and Comparative Immunology, 30, 175-186.
107. Zinkernagel, R. M., Hilpert, H., & Gerber, H. (1972). The digestion of colostral bovine immunoglobulins in infants. Experientia, 28, 741.